MNPR — Monopar Therapeutics Inc. | XLV Holdings | StockAdder

(MNPR)

Monopar Therapeutics Inc.

Live chart and latest MNPR stock news.

Sector ETF → XLV Health Care Select

Chart powered byTradingView— professional charts for every trader.Try it free →

MNPR News

Institutional investors in Monopar Therapeutics Inc. (NASDAQ:MNPR) see US$66m decrease in market cap last week, although long-term gains have benefitted them.

Feb 11, 2026 Stock Titan

Wilson disease drug heads for mid-2026 filing as Monopar cash lasts to 2027

Mar 27, 2026 The Globe and Mail

Monopar Therapeutics Inc (MNPR) Receives a Buy from Lake Street

Mar 31, 2026 Stock Traders Daily

How Monopar Therapeutics Inc. (MNPR) Affects Rotational Strategy Timing

Mar 24, 2026 simplywall.st

Is There An Opportunity With Monopar Therapeutics Inc.'s (NASDAQ:MNPR) 46% Undervaluation?

Nov 22, 2025 Intellectia AI

MNPR Stock News Today | Earnings, Events & Price Alerts

Apr 4, 2026 Investor's Business Daily

Monopar Therapeutics, A Top 1% Biotech Stock, Just Surged Into A Breakout. Here's Why.

Sep 15, 2025 Stock Titan

[Form 4] Monopar Therapeutics Insider Trading Activity

Apr 2, 2026 Yahoo Finance

Raymond James Boosts Monopar Therapeutics (MNPR) PT to $142, Maintains Strong Buy

Oct 16, 2025 simplywall.st

Independent Director Arthur Klausner Sold A Bunch Of Shares In Monopar Therapeutics

Dec 21, 2025 The Globe and Mail

Wall Street Analysts Are Bullish on Top Healthcare Picks

Mar 31, 2026 Stock Titan

Monopar (NASDAQ: MNPR) details 2025 loss and ALXN1840 NDA plan

Mar 27, 2026 Yahoo Finance

Why Monopar Therapeutics Inc. (MNPR) is Surging in 2025

Apr 30, 2025 Stock Titan

MNPR SEC Filings - Monopar Therapeutics Inc 10-K, 10-Q, 8-K Forms

Mar 31, 2026 Stock Titan

Monopar Therapeutics (MNPR) COO gains shares through RSU vesting and tax withholding